Business Context and Reporting Period
This Form 8-K Current Report was filed by Supernus Pharmaceuticals, Inc. on May 11, 2018, covering events that occurred on May 8, 2018. The filing addresses corporate governance matters specifically related to executive compensation and retention agreements.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on contractual amendments regarding executive compensation rather than financial performance results.
Material Changes
On May 8, 2018, the Company executed the following material changes to executive agreements:
- CEO Employment Agreement: Entered into the Third Amendment to the Amended and Restated Employment Agreement with Jack Khattar, President and Chief Executive Officer.
- Executive Retention Agreements: Entered into amendments with certain key executives regarding their existing Retention Agreements.
- Clawback Policy Application: The amendments stipulate that all amounts payable under these agreements are subject to the Company's Clawback Policy, effective April 23, 2018, regardless of the policy's original effective date.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, or management commentary on business operations. The primary risk and contingency disclosed relates to the Clawback Policy, which allows the Board of Directors to recover incentive compensation from covered executives if:
- The Board determines the executive engaged in fraud, intentional misconduct, or gross negligence requiring a material restatement of financial results; and
- Such misconduct resulted in an incorrect determination that an incentive compensation performance goal was achieved.
- Recovery may apply to compensation paid during the three-year period preceding the filing of the accounting restatement.
Investor Verification Checklist
- Verify the specific terms of the Third Amendment to the CEO Employment Agreement (Exhibit 10.1).
- Review the Form of Amendment to the Executive Retention Agreement (Exhibit 10.2) to understand the scope of executives covered.
- Confirm the full text of the Clawback Policy effective April 23, 2018, to understand the specific triggers for compensation recovery.
- Check subsequent filings for any financial restatements that might trigger the newly applied clawback provisions.